These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 18211407)

  • 1. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature.
    Alijotas-Reig J; Garcia-Gimenez V
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):150-61. PubMed ID: 18211407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed immune-mediated adverse effects of polyalkylimide dermal fillers: clinical findings and long-term follow-up.
    Alijotas-Reig J; Garcia-Gimenez V; Miró-Mur F; Vilardell-Tarrés M
    Arch Dermatol; 2008 May; 144(5):637-42. PubMed ID: 18490590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management, and follow-up.
    Alijotas-Reig J; Garcia-Gimenez V; Miró-Mur F; Vilardell-Tarrés M
    Dermatol Surg; 2009 Feb; 35 Suppl 1():360-6. PubMed ID: 19207326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid skin fillers: adverse reactions and skin testing.
    Lowe NJ; Maxwell CA; Lowe P; Duick MG; Shah K
    J Am Acad Dermatol; 2001 Dec; 45(6):930-3. PubMed ID: 11712042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions to dermal fillers: a review of European experiences.
    Andre P; Lowe NJ; Parc A; Clerici TH; Zimmermann U
    J Cosmet Laser Ther; 2005 Dec; 7(3-4):171-6. PubMed ID: 16414905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to injectable soft tissue permanent fillers.
    Christensen L; Breiting V; Janssen M; Vuust J; Hogdall E
    Aesthetic Plast Surg; 2005; 29(1):34-48. PubMed ID: 15759096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients.
    Wiest LG; Stolz W; Schroeder JA
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1681-8. PubMed ID: 19807764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler.
    Sidwell RU; Dhillon AP; Butler PE; Rustin MH
    Clin Exp Dermatol; 2004 Nov; 29(6):630-2. PubMed ID: 15550141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up.
    Alijotas-Reig J; Garcia-Gimenez V; Vilardell-Tarres M
    Dermatology; 2009; 219(4):303-8. PubMed ID: 19797889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foreign body granulomatous reactions to cosmetic fillers: a clinical study of 15 cases.
    Sanchis-Bielsa JM; Bagán JV; Poveda R; Salvador I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):237-41. PubMed ID: 19615662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study.
    Baumann LS; Shamban AT; Lupo MP; Monheit GD; Thomas JA; Murphy DK; Walker PS;
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S128-35. PubMed ID: 18086050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid.
    Arron ST; Neuhaus IM
    J Cosmet Dermatol; 2007 Sep; 6(3):167-71. PubMed ID: 17760694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioengineered hyaluronic acid elicited a nonantigenic T cell activation: implications from cosmetic medicine and surgery to nanomedicine.
    Alijotas-Reig J; Hindié M; Kandhaya-Pillai R; Miro-Mur F
    J Biomed Mater Res A; 2010 Oct; 95(1):180-90. PubMed ID: 20564542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel.
    Angus JE; Affleck AG; Leach IH; Millard LG
    Br J Dermatol; 2006 Nov; 155(5):1077-8. PubMed ID: 17034549
    [No Abstract]   [Full Text] [Related]  

  • 15. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers.
    Christensen LH
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1612-9. PubMed ID: 19807755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective multicenter study for evaluation of safety, efficacy, and esthetic results of cross-linked polyacrylamide hydrogel in 81 patients.
    Wolters M; Lampe H
    Dermatol Surg; 2009 Feb; 35 Suppl 1():338-43. PubMed ID: 19207323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.
    Smith KC
    Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use.
    Rzany B; Becker-Wegerich P; Bachmann F; Erdmann R; Wollina U
    J Cosmet Dermatol; 2009 Dec; 8(4):317-23. PubMed ID: 19958438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep.
    Bergeret-Galley C; Latouche X; Illouz YG
    Aesthetic Plast Surg; 2001; 25(4):249-55. PubMed ID: 11568826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid.
    Rossner M; Rossner F; Bachmann F; Wiest L; Rzany B
    Dermatol Surg; 2009 Feb; 35 Suppl 1():367-74. PubMed ID: 19207327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.